Helixon Biotechnology (Suzhou) Co., Ltd
4 clinical trials · Sponsor
◉ Watch Helixon Biotechnology (Suzhou) Co., Ltd
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Safety, Tolerability, PK and Preliminary Efficacy of HX15001 Combined With Etrasimod in Moderate-severe Ulcerative Colitis (NCT07768254) | Helixon Biotechnology (Suzhou) Co., Ltd | 2026-09-09 |
| A Dose Escalation Phase 1 Study of HXN5003 in Healthy Participants (NCT07549750) | Helixon Biotechnology (Suzhou) Co., Ltd | 2026-05-27 |
| Phase I Study of HXN6005 in Adult Healthy Participants (NCT07449741) | Helixon Biotechnology (Suzhou) Co., Ltd | 2026-04-27 |
| Study of HX15001 in Adult Healthy Volunteers. (NCT06999720) | Helixon Biotechnology (Suzhou) Co., Ltd | 2025-06-11 |
Track Helixon Biotechnology (Suzhou) Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.